Latest filing published 18 Aug 2026 for Lexeo Therapeutics, Inc., €5,579.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Otero Jose Manuel is a declared insider of Lexeo Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 1 July 2026 to 18 August 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 18 August 2026, reports a transaction of €5,579 in Lexeo Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations